CGMP Lentivirus Production
As the number and variety of planned CAR-T and gene therapy trials increases with each year, the need for CGMP lentivirus also continues to grow. At Vigene, we are passionate about our mission to help support scientists advance their biomedical research and, ultimately, to make gene therapy affordable and accessible to those in need. As a leader in CGMP lentivirus production, we have the experience and dedication to quality that you need to scale up your lentivirus gene therapy project into a patient-ready product. We know that there is no single production strategy that works best for all CGMP lentivirus projects, so we offer the flexibility of multiple lentivirus production methods and the expert knowledge to help you decide which process will best meet your individual needs.
Interested in CGMP lentivirus production? Contact us today for a free consultation >